News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
424,043 Results
Type
Article (17193)
Company Profile (42)
Press Release (406808)
Multimedia
Podcasts (46)
Webinars (11)
Section
Business (135743)
Career Advice (1339)
Deals (27132)
Drug Delivery (73)
Drug Development (39752)
Employer Resources (94)
FDA (12343)
Job Trends (8640)
News (221245)
Policy (20301)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (3)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
Academia (738)
Accelerated approval (6)
Adcomms (7)
Allergies (50)
Alliances (32143)
ALS (53)
Alzheimer's disease (705)
Antibody-drug conjugate (ADC) (85)
Approvals (12391)
Artificial intelligence (242)
Autoimmune disease (13)
Automation (11)
Bankruptcy (237)
Best Places to Work (6979)
BIOSECURE Act (15)
Biosimilars (104)
Biotechnology (30)
Bladder cancer (37)
Brain cancer (19)
Breast cancer (117)
Cancer (1176)
Cardiovascular disease (109)
Career advice (1086)
Career pathing (29)
CAR-T (73)
Cell therapy (225)
Cervical cancer (14)
Clinical research (33702)
Collaboration (508)
Compensation (193)
Complete response letters (9)
COVID-19 (976)
CRISPR (20)
C-suite (148)
Cystic fibrosis (47)
Data (1143)
Decentralized trials (2)
Denatured (13)
Depression (28)
Diabetes (187)
Diagnostics (4566)
Digital health (17)
Diversity (1)
Diversity, equity & inclusion (16)
Drug discovery (102)
Drug pricing (70)
Drug shortages (27)
Duchenne muscular dystrophy (57)
Earnings (64357)
Editorial (35)
Employer branding (15)
Employer resources (73)
Events (52007)
Executive appointments (470)
FDA (13229)
Featured Employer (14)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (440)
Gene editing (48)
Generative AI (22)
Gene therapy (175)
GLP-1 (535)
Government (1943)
Grass and pollen (5)
Guidances (42)
Healthcare (10083)
Huntington's disease (11)
IgA nephropathy (17)
Immunology and inflammation (76)
Indications (20)
Infectious disease (1070)
Inflammatory bowel disease (73)
Inflation Reduction Act (6)
Influenza (29)
Intellectual property (65)
Interviews (232)
IPO (13033)
IRA (24)
Job creations (1875)
Job search strategy (916)
Kidney cancer (8)
Labor market (42)
Layoffs (264)
Leadership (13)
Legal (4444)
Liver cancer (41)
Lung cancer (181)
Lymphoma (84)
Machine learning (4)
Management (24)
Manufacturing (232)
MASH (51)
Medical device (10275)
Medtech (10279)
Mergers & acquisitions (14604)
Metabolic disorders (516)
Multiple sclerosis (54)
NASH (10)
Neurodegenerative disease (55)
Neuropsychiatric disorders (17)
Neuroscience (1004)
NextGen: Class of 2025 (3563)
Non-profit (1199)
Northern California (1395)
Now hiring (37)
Obesity (288)
Opinion (172)
Ovarian cancer (41)
Pain (62)
Pancreatic cancer (45)
Parkinson's disease (66)
Partnered (16)
Patents (169)
Patient recruitment (67)
Peanut (26)
People (34017)
Pharmaceutical (14)
Pharmacy benefit managers (17)
Phase I (8732)
Phase II (14149)
Phase III (12936)
Pipeline (885)
Policy (90)
Postmarket research (1389)
Preclinical (3426)
Press Release (38)
Prostate cancer (62)
Psychedelics (16)
Radiopharmaceuticals (142)
Rare diseases (221)
Real estate (3328)
Recruiting (41)
Regulatory (15274)
Reports (45)
Research institute (823)
Resumes & cover letters (226)
Rett syndrome (1)
RNA editing (2)
RSV (36)
Schizophrenia (46)
Series A (72)
Series B (47)
Service/supplier (9)
Sickle cell disease (30)
Southern California (1314)
Special edition (16)
Spinal muscular atrophy (72)
Sponsored (22)
Startups (2068)
State (1)
Stomach cancer (6)
Supply chain (53)
Tariffs (25)
The Weekly (32)
United States (13208)
Vaccines (332)
Venture capitalists (29)
Weight loss (220)
Women's health (17)
Worklife (15)
Date
Today (16)
Last 7 days (400)
Last 30 days (1529)
Last 365 days (21164)
2025 (6649)
2024 (22481)
2023 (25252)
2022 (34020)
2021 (36434)
2020 (34170)
2019 (28166)
2018 (21564)
2017 (21523)
2016 (19288)
2015 (23127)
2014 (17448)
2013 (14326)
2012 (16092)
2011 (16619)
2010 (15230)
Location
Africa (423)
Alabama (33)
Alaska (1)
Arizona (102)
Arkansas (9)
Asia (27893)
Australia (4537)
California (3320)
Canada (1277)
China (342)
Colorado (172)
Connecticut (166)
Delaware (70)
Europe (58937)
Florida (600)
Georgia (147)
Idaho (33)
Illinois (322)
India (23)
Indiana (210)
Iowa (4)
Japan (117)
Kansas (67)
Kentucky (4)
Louisiana (8)
Maine (52)
Maryland (488)
Massachusetts (2126)
Michigan (154)
Minnesota (236)
Mississippi (2)
Missouri (57)
Montana (19)
Nebraska (18)
Nevada (36)
New Hampshire (56)
New Jersey (1208)
New Mexico (22)
New York (1103)
North Carolina (582)
North Dakota (4)
Northern California (1395)
Ohio (131)
Oklahoma (8)
Oregon (13)
Pennsylvania (755)
Puerto Rico (6)
Rhode Island (19)
South America (751)
South Carolina (20)
Southern California (1314)
Tennessee (74)
Texas (523)
Utah (109)
Virginia (65)
Washington D.C. (34)
Washington State (362)
West Virginia (3)
Wisconsin (32)
424,043 Results for "communitech market intelligence".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry
March 27, 2025
·
4 min read
Press Releases
Artificial Intelligence (AI) in Life Sciences Market Size to Worth USD 13.89 Bn by 2034
February 18, 2025
·
1 min read
Job Trends
Bonus Episode: Q1 2025 Job Market Update
In this bonus episode,
BioSpace’s
vice president of marketing
Chantal Dresner
and careers editor
Angela Gabriel
take a look at Q1 job market performance, layoffs and administration decisions impacting the workforce.
April 15, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Artificial Intelligence In Precision Medicine Market to Reach USD 37.60 Bn to 2034
December 18, 2024
·
1 min read
Tariffs
Pharmas Bleed Value as Trump Tariffs Roil Global Markets
Billions in market cap are being shed as the markets reel over President Donald Trump’s escalating trade war. Eli Lilly’s value has dropped more than $95 billion in just one month.
April 9, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Artificial Intelligence in Diagnostics Market Size to Hit USD 8.54 Bn by 2033
December 3, 2024
·
1 min read
Artificial Intelligence in Genomics Market Size US$ 16,431.16 Million by 2033
The global artificial intelligence in genomics market size was evaluated at US$ 560 million in 2023 and is expected to attain around US$ 16,431.16 million by 2033, growing at a CAGR of 40.2% from 2024 to 2033.
May 14, 2024
·
11 min read
MASH
7 Late-Stage MASH Candidates That Could Reshape the Market
Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic dysfunction-associated steatohepatitis to a market that could reach $16 billion by 2033.
April 7, 2025
·
6 min read
·
Ben Hargreaves
Press Releases
Delirium Market Size to Reach USD 294.0 Million by 2035, Impelled by Advancements in Early Detection.
Delirium Market Outlook 2025-2035:
February 17, 2025
·
8 min read
Press Releases
Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference
November 21, 2024
·
1 min read
1 of 42,405
Next
